Global Lorlatinib Market Growth 2022-2028
- LP 4768425
- 73 Pages
- January 2022
- Pharmaceuticals
The United States Lorlatinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lorlatinib market, reaching US$ million by the year 2028. As for the Europe Lorlatinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lorlatinib players cover Pfizer, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lorlatinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tables 25mg
Tables 100mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lorlatinib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lorlatinib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lorlatinib by Country/Region, 2017, 2022 & 2028
2.2 Lorlatinib Segment by Type
2.2.1 Tables 25mg
2.2.2 Tables 100mg
2.3 Lorlatinib Sales by Type
2.3.1 Global Lorlatinib Sales Market Share by Type (2017-2022)
2.3.2 Global Lorlatinib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lorlatinib Sale Price by Type (2017-2022)
2.4 Lorlatinib Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Lorlatinib Sales by Application
2.5.1 Global Lorlatinib Sale Market Share by Application (2017-2022)
2.5.2 Global Lorlatinib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lorlatinib Sale Price by Application (2017-2022)
3 Global Lorlatinib by Company
3.1 Global Lorlatinib Breakdown Data by Company
3.1.1 Global Lorlatinib Annual Sales by Company (2020-2022)
3.1.2 Global Lorlatinib Sales Market Share by Company (2020-2022)
3.2 Global Lorlatinib Annual Revenue by Company (2020-2022)
3.2.1 Global Lorlatinib Revenue by Company (2020-2022)
3.2.2 Global Lorlatinib Revenue Market Share by Company (2020-2022)
3.3 Global Lorlatinib Sale Price by Company
3.4 Key Manufacturers Lorlatinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lorlatinib Product Location Distribution
3.4.2 Players Lorlatinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lorlatinib by Geographic Region
4.1 World Historic Lorlatinib Market Size by Geographic Region (2017-2022)
4.1.1 Global Lorlatinib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lorlatinib Annual Revenue by Geographic Region
4.2 World Historic Lorlatinib Market Size by Country/Region (2017-2022)
4.2.1 Global Lorlatinib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lorlatinib Annual Revenue by Country/Region
4.3 Americas Lorlatinib Sales Growth
4.4 APAC Lorlatinib Sales Growth
4.5 Europe Lorlatinib Sales Growth
4.6 Middle East & Africa Lorlatinib Sales Growth
5 Americas
5.1 Americas Lorlatinib Sales by Country
5.1.1 Americas Lorlatinib Sales by Country (2017-2022)
5.1.2 Americas Lorlatinib Revenue by Country (2017-2022)
5.2 Americas Lorlatinib Sales by Type
5.3 Americas Lorlatinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lorlatinib Sales by Region
6.1.1 APAC Lorlatinib Sales by Region (2017-2022)
6.1.2 APAC Lorlatinib Revenue by Region (2017-2022)
6.2 APAC Lorlatinib Sales by Type
6.3 APAC Lorlatinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lorlatinib by Country
7.1.1 Europe Lorlatinib Sales by Country (2017-2022)
7.1.2 Europe Lorlatinib Revenue by Country (2017-2022)
7.2 Europe Lorlatinib Sales by Type
7.3 Europe Lorlatinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lorlatinib by Country
8.1.1 Middle East & Africa Lorlatinib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lorlatinib Revenue by Country (2017-2022)
8.2 Middle East & Africa Lorlatinib Sales by Type
8.3 Middle East & Africa Lorlatinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lorlatinib
10.3 Manufacturing Process Analysis of Lorlatinib
10.4 Industry Chain Structure of Lorlatinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lorlatinib Distributors
11.3 Lorlatinib Customer
12 World Forecast Review for Lorlatinib by Geographic Region
12.1 Global Lorlatinib Market Size Forecast by Region
12.1.1 Global Lorlatinib Forecast by Region (2023-2028)
12.1.2 Global Lorlatinib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lorlatinib Forecast by Type
12.7 Global Lorlatinib Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Lorlatinib Product Offered
13.1.3 Pfizer Lorlatinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Lorlatinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lorlatinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tables 25mg
Table 4. Major Players of Tables 100mg
Table 5. Global Lorlatinib Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Lorlatinib Sales Market Share by Type (2017-2022)
Table 7. Global Lorlatinib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Lorlatinib Revenue Market Share by Type (2017-2022)
Table 9. Global Lorlatinib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Lorlatinib Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Lorlatinib Sales Market Share by Application (2017-2022)
Table 12. Global Lorlatinib Revenue by Application (2017-2022)
Table 13. Global Lorlatinib Revenue Market Share by Application (2017-2022)
Table 14. Global Lorlatinib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Lorlatinib Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Lorlatinib Sales Market Share by Company (2020-2022)
Table 17. Global Lorlatinib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Lorlatinib Revenue Market Share by Company (2020-2022)
Table 19. Global Lorlatinib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Lorlatinib Producing Area Distribution and Sales Area
Table 21. Players Lorlatinib Products Offered
Table 22. Lorlatinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lorlatinib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Lorlatinib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Lorlatinib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Lorlatinib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Lorlatinib Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Lorlatinib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Lorlatinib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Lorlatinib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Lorlatinib Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Lorlatinib Sales Market Share by Country (2017-2022)
Table 35. Americas Lorlatinib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Lorlatinib Revenue Market Share by Country (2017-2022)
Table 37. Americas Lorlatinib Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Lorlatinib Sales Market Share by Type (2017-2022)
Table 39. Americas Lorlatinib Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Lorlatinib Sales Market Share by Application (2017-2022)
Table 41. APAC Lorlatinib Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Lorlatinib Sales Market Share by Region (2017-2022)
Table 43. APAC Lorlatinib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Lorlatinib Revenue Market Share by Region (2017-2022)
Table 45. APAC Lorlatinib Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Lorlatinib Sales Market Share by Type (2017-2022)
Table 47. APAC Lorlatinib Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Lorlatinib Sales Market Share by Application (2017-2022)
Table 49. Europe Lorlatinib Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Lorlatinib Sales Market Share by Country (2017-2022)
Table 51. Europe Lorlatinib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Lorlatinib Revenue Market Share by Country (2017-2022)
Table 53. Europe Lorlatinib Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Lorlatinib Sales Market Share by Type (2017-2022)
Table 55. Europe Lorlatinib Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Lorlatinib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Lorlatinib Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Lorlatinib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Lorlatinib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Lorlatinib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Lorlatinib Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Lorlatinib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Lorlatinib Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Lorlatinib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Lorlatinib
Table 66. Key Market Challenges & Risks of Lorlatinib
Table 67. Key Industry Trends of Lorlatinib
Table 68. Lorlatinib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Lorlatinib Distributors List
Table 71. Lorlatinib Customer List
Table 72. Global Lorlatinib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Lorlatinib Sales Market Forecast by Region
Table 74. Global Lorlatinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Lorlatinib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Lorlatinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Lorlatinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Lorlatinib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Lorlatinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Lorlatinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Lorlatinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Lorlatinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Lorlatinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Lorlatinib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Lorlatinib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Lorlatinib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Lorlatinib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Lorlatinib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Lorlatinib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Lorlatinib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Lorlatinib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Basic Information, Lorlatinib Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Lorlatinib Product Offered
Table 94. Pfizer Lorlatinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Lorlatinib
Figure 2. Lorlatinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lorlatinib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Lorlatinib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lorlatinib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tables 25mg
Figure 10. Product Picture of Tables 100mg
Figure 11. Global Lorlatinib Sales Market Share by Type in 2021
Figure 12. Global Lorlatinib Revenue Market Share by Type (2017-2022)
Figure 13. Lorlatinib Consumed in Squamous Cell Carcinoma of NSCLC
Figure 14. Global Lorlatinib Market: Squamous Cell Carcinoma of NSCLC (2017-2022) & (K Pcs)
Figure 15. Lorlatinib Consumed in Adenocarcinoma of NSCLC
Figure 16. Global Lorlatinib Market: Adenocarcinoma of NSCLC (2017-2022) & (K Pcs)
Figure 17. Lorlatinib Consumed in Large Cell Carcinoma of NSCLC
Figure 18. Global Lorlatinib Market: Large Cell Carcinoma of NSCLC (2017-2022) & (K Pcs)
Figure 19. Global Lorlatinib Sales Market Share by Application (2017-2022)
Figure 20. Global Lorlatinib Revenue Market Share by Application in 2021
Figure 21. Lorlatinib Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Lorlatinib Revenue Market Share by Company in 2021
Figure 23. Global Lorlatinib Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Lorlatinib Revenue Market Share by Geographic Region in 2021
Figure 25. Global Lorlatinib Sales Market Share by Region (2017-2022)
Figure 26. Global Lorlatinib Revenue Market Share by Country/Region in 2021
Figure 27. Americas Lorlatinib Sales 2017-2022 (K Pcs)
Figure 28. Americas Lorlatinib Revenue 2017-2022 ($ Millions)
Figure 29. APAC Lorlatinib Sales 2017-2022 (K Pcs)
Figure 30. APAC Lorlatinib Revenue 2017-2022 ($ Millions)
Figure 31. Europe Lorlatinib Sales 2017-2022 (K Pcs)
Figure 32. Europe Lorlatinib Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Lorlatinib Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Lorlatinib Revenue 2017-2022 ($ Millions)
Figure 35. Americas Lorlatinib Sales Market Share by Country in 2021
Figure 36. Americas Lorlatinib Revenue Market Share by Country in 2021
Figure 37. United States Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Lorlatinib Sales Market Share by Region in 2021
Figure 42. APAC Lorlatinib Revenue Market Share by Regions in 2021
Figure 43. China Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Lorlatinib Sales Market Share by Country in 2021
Figure 50. Europe Lorlatinib Revenue Market Share by Country in 2021
Figure 51. Germany Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Lorlatinib Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Lorlatinib Revenue Market Share by Country in 2021
Figure 58. Egypt Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Lorlatinib Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Lorlatinib in 2021
Figure 64. Manufacturing Process Analysis of Lorlatinib
Figure 65. Industry Chain Structure of Lorlatinib
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
